Quarter ended Sept 2026: consolidated revenue up 1.9%, profit after tax down 47.7% year on year
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
In the quarter ended Sept 30, 2026, consolidated revenue was Rs 13,267.44 lakh, up 1.9% from Rs 13,022.27 lakh a year earlier; profit after tax fell 47.7% to Rs 943.72 lakh from Rs 1,802.92 lakh. Profit before interest, tax, depreciation and amortisation was 15.2% of revenue, down from 20.5%. Half-year consolidated profit after tax was Rs 1,896.87 lakh and operating cash flow positive at Rs 5,479.21 lakh. The review opinion was unmodified.
Shareholders may see pressure on earnings and margins despite slightly higher revenue; positive cash flow and an unmodified review offer some support.
The filed figures for this quarter have not reached us in XBRL yet, so there is nothing to compute here; the read above is the AI's, from the document. The table appears the moment the figures land.